title: Galactomannan gum coated mucoadhesive microspheres of glipizide for treatment of type 2 diabetes mellitus: In vitro and in vivo evaluation.
abstract: Type 2 diabetes mellitus is a heterogeneous disease of polygenic origin and involves both defective insulin secretion and peripheral insulin resistance. Studies have shown that post-meal hyperglycemic spikes are associated with increased cardiovascular mortality in type 2 diabetes. Over the past decade, a major interest in control of postprandial glucose excursion has emerged and a plethora of new medications that specifically target postprandial hyperglycemia were discovered. Despite the availability of new agents for treatment of type 2 diabetes mellitus, oral sulfonylureas remain a cornerstone of therapy, because they are relatively inexpensive and are well tolerated. However, hypoglycemia is a major safety concern with sulfonylureas and it is one major risk factor requiring hospitalization. Glipizide is a potent, rapid-acting with short duration of action and well tolerated second-generation sulfonylurea effective in reducing postprandial glucose levels. However, risk of postprandial hypoglycemia and post-meal glucose excursions, if dose missed before meal; are always associated with the use of glipizide for treatment of type 2 diabetes mellitus. Since, the site of absorption of glipizide is from stomach thus dosage forms that are retained in stomach by mucoadhesion; would increase absorption, improve drug efficiency and decrease dose requirements. Microsphere carrier systems made by using polymer galactomannan having strong mucoadhesive properties and easily biodegradable could be an attractive strategy to formulate. The purpose of this research work is to formulate galactomannan coated mucoadhesive microspheres of glipizide and systematically evaluate its in vitro characteristics and in vivo performance for sustained glucose lowering effect and improvement in diabetic condition as compared to immediate release of glipizide.
authors: Department of Pharmaceutical Sciences, ASBASJSM College of Pharmacy, Bela (Ropar) 140111, Punjab, India.
authors: Punam
authors: P
authors: Gaba
authors: Sarbjot
authors: S
authors: Singh
authors: Monika
authors: M
authors: Gaba
authors: G D
authors: GD
authors: Gupta
keywords: Diabetes; Galactomannan; Glipizide; Mucoadhesive microspheres
references: J Microencapsul. 2002 Jul-Aug;19(4):511-22
references: 12396387
references: Chem Pharm Bull (Tokyo). 1992 Aug;40(8):2155-8
references: 1423772
references: AAPS PharmSciTech. 2000 Nov 13;1(4):E32
references: 14727897
references: Int J Pharm. 2000 Jul 20;202(1-2):173-8
references: 10915941
references: Pharm Res. 2001 Nov;18(11):1600-6
references: 11758769
references: J Drug Target. 2004;12(7):435-42
references: 15621668
references: Int J Pharm. 2003 Apr 14;255(1-2):13-32
references: 12672598
references: J Control Release. 1998 Feb 12;51(2-3):281-7
references: 9685926
references: J Control Release. 1998 Feb 12;51(2-3):115-22
references: 9685908
references: Eur J Pharm Biopharm. 2002 Jan;53(1):87-98
references: 11777756
references: AAPS PharmSciTech. 2003;4(2):E28
references: 12916910
references: AAPS PharmSciTech. 2003;4(3):E39
references: 14621971
references: Aliment Pharmacol Ther. 1987 Aug;1(4):273-80
references: 2979672
references: Endocrinology. 2002 Feb;143(2):339-42
references: 11796484
references: Eur J Pharm Sci. 2002 Aug;16(3):185-92
references: 12128173
references: AAPS PharmSciTech. 2006 May 26;7(2):E47
references: 16796364
references: J Biomed Mater Res. 1997 Jan;34(1):21-8
references: 8978649